(BioCision: San Rafael, CA) -- BioCision LLC, a life science research and development company that standardizes basic laboratory processes, has announced the formation of MedCision Inc., an independent company focused on automation of pre-clinical and clinical processes.

“The formation of MedCision is driven by a critical need in the market for innovative standardization technologies and solutions for translational, clinical, and point-of-care settings,” says Rolf O. Ehrhardt, M.D., Ph.D., BioCision CEO. “MedCision will be a leader in developing and commercializing innovative instruments for crucial processes in the post-manufacturing cell and gene therapy space.”

“The name of the company, MedCision, creates a clear connection to our BioCision roots but also conveys an evolution from those roots as our technology will focus on automating point-of-care clinical processes,” continues Ehrhardt.

 …